Metabolic Signatures and Diagnostic Prediction Models for Coronary Artery Disease and Type 2 Diabetes Mellitus: Insights From an Exploratory Study
Authors:
- Ying LiYLYing Li
- Yapei LiYLYapei Li
- Ting PengTPTing Peng
- Hans StrijdomHSHans Strijdom
- Jiangang WangJWJiangang Wang
- Jianping WengJianping Weng
Open Access
- 28 November 2025
- journal article
- Published by Wiley in iNew Medicine
- Vol. 2 (2)
Abstract
Coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) often coexist and mutually exacerbate each other by shared mechanisms (including deregulated glucolipid metabolism and insulin resistance), yet their global metabolic signature remain poorly characterized. In this exploratory study, we collected serum samples from 21 CAD patients, 20 T2DM subjects, and 20 healthy individuals (HH). Metabolomics and lipidomics were performed, and bioinformatics analysis identified disease‐related pathways and biomarkers. A machine learning‐based diagnostic prediction model was built using these metabolic biomarkers. Our analysis unveiled significant metabolic resemblance between CAD and T2DM. Apart from higher covariates such as age and weight compared to the healthy population, both conditions demonstrated elevated levels of triglycerides (TGs), diglycerides (DGs), phosphatidylcholines (PCs), and phosphatidylethanolamines (PEs). Concurrently, lipid metabolism‐related signaling pathways were notably activated. Machine learning identified seven lipid metabolites (e.g., TG 16:0/16:0/18:3, PC 31:1, and PE 34:1) that exhibited an auROC ≥ 0.9 for both CAD and T2DM, suggesting their potential as shared biomarkers. A prediction model based on 7‐metabolites achieved predictive accuracies exceeding 95% and 92% for CAD and T2DM, respectively. Furthermore, the model also demonstrated predictive accuracies surpassing 98% and 95% in an external validation cohort, highlighting its robust predictive performance. Through this exploratory study, we have preliminarily delineated the metabolic signatures of CAD and T2DM, and further strengthened the intrinsic relationship between the two diseases from a metabolic perspective.Keywords
This publication has 35 references indexed in Scilit:
- Multi‐omics analysis revealed biomarkers for coronary atherosclerosis: Occurrence and developmentClinical and Translational Medicine, 2025
- Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 DiabetesMolecular Nutrition & Food Research, 2025
- Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 DiabetesJAMA, 2024
- Clinical predictive factors and prediction models for end‐stage renal disease in Chinese patients with type 2 diabetes mellitusClinical and Translational Medicine, 2023
- Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran ProgramJAMA Cardiology, 2023
- Complex heatmap visualizationiMeta, 2022
- Shared components of heritability across genetically correlated traitsThe American Journal of Human Genetics, 2022
- Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetesAnnals of Clinical and Translational Neurology, 2021
- A review on coronary artery disease, its risk factors, and therapeuticsJournal of Cellular Physiology, 2019
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011